#hnc healthcare group
Explore tagged Tumblr posts
Text
Dr. Shanith Mangalat |Chairman & Founder, Ourshopee.com
Dr Shanith carries many labels with him; entrepreneur, doctor, businessman, visionary and more. The chairman and CEO of hnc Healthcare Group, founder and chairman of Ourshopee.com, founder and chairman of Ruky Perfumes, and chairman of DSR Holdings, he carries all these roles and responsibilities with utmost zeal and passion.
Dr Shanith Mangalat is Chairman of DRS Holdings based in UAE , with Investments in more than 29 Operating companies with aggregate annual revenues of more than US $100 Million. He chairs the boards of several group operating companies, including Our Shopee Online Store, HNC Healthcare Group, Rukyperfumes,Medco Pharmaceuticals, Elony Electronics, Bioplus ,Transmoni Payments India Pvt. Ltd.,TranxPay India Pvt. Ltd. WR Solution Pvt. Ltd. , Zon foods Global Ltd. The DRS Holdings companies include 29 private-listed corporations .Earlier Under his leadership, DRS division of Telelink , An IT and telecom retail stores chain which was his brain child was acquired by Giant based for 15 Million USD. His other company Ourshopee.com has also been placed among the ‘big10’ most valuable online shopping portal in the GCC Region. Dr Shanith Mangalat is in demand as a speaker on the international ecommerce conference circuit. His strategic insights and exciting style make him a popular choice.
Best Young Indian visionary Award 2017 by IPA Best Health Care Brand, Golden Achievements Award, Dubai 5th Edition 2018 Best Health Care Brand Award by Middle East Chandrika 2018 Asian Business Award 2019 By Arab Asian Chamber of Commerce - Hyderabad Global Leadership Award 2019 By American Leadership Development Association (ALDA) and Leaders Magazine ,Malaysia
Dr. Shanith Mangalat is MBBS Graduate from Yenapoya University, Mangalore and Specialist studies in Family Medicine, RCGP, UK and post graduated in Diabetology from India’s most Prestigious Apollo Hospitals Institute, Hyderabad.
Thanks & Regards
Email: [email protected]
Mobile : +971 56 433 4980
Website: https://www.drsholdings.ae/
0 notes
Text
Lasers, Wellness, and Beyond: Navigating the Acupuncture Lasers Market
Introduction
Acupuncture, an ancient healing practice rooted in traditional Chinese medicine, has gained popularity worldwide for its holistic approach to health and wellness. In recent years, the integration of modern technology has given rise to the Acupuncture Lasers market, revolutionizing the way acupuncture is performed and enhancing its effectiveness. This article explores the dynamics of the Acupuncture Lasers market, including its growth drivers, market trends, key players, and the potential benefits it offers to patients.
Market Overview
The global Acupuncture Lasers market has witnessed steady growth over the past decade, driven by an increasing demand for non-invasive, painless, and efficient acupuncture therapy. Acupuncture lasers offer an alternative to traditional needle-based acupuncture, making it an attractive option for individuals who may have reservations about needles. These lasers are designed to stimulate acupuncture points on the body, promoting the flow of energy or "qi" to alleviate various health conditions.
Market Growth Drivers
1. Rising Awareness and Acceptance: Increased awareness about the effectiveness of acupuncture lasers in pain management, stress relief, and various health issues has led to growing acceptance among both patients and healthcare professionals. The shift towards natural and non-pharmacological treatment options has been a significant growth driver.
2. Advancements in Laser Technology: Continuous advancements in laser technology have improved the precision and safety of acupuncture lasers. Newer models are equipped with adjustable settings, making them suitable for a wide range of applications, from acupuncture to beauty treatments and physiotherapy.
3. Aging Population: The global population is aging, leading to a rise in chronic health conditions and pain-related issues. Acupuncture lasers are considered a viable solution for addressing these health concerns, contributing to market growth.
4. Expanding Holistic Healthcare: Many individuals are seeking holistic and alternative healthcare options. Acupuncture lasers align with this trend, offering a non-invasive and drug-free approach to healing, which has propelled their demand.
Market Trends
1. Portable and User-Friendly Devices: One of the notable trends in the Acupuncture Lasers market is the development of portable and user-friendly devices. These allow practitioners to provide treatments in diverse settings, such as homes, clinics, and wellness centers, expanding the reach of acupuncture services.
2. Integration with Digital Health: The integration of acupuncture lasers with digital health technologies, such as mobile apps and telemedicine, is becoming more common. This enables practitioners to monitor and adjust treatment plans remotely, enhancing patient outcomes.
3. Multi-Modality Platforms: Some manufacturers are incorporating multiple treatment modalities into their devices. This means that a single device can offer acupuncture, low-level laser therapy, and other complementary treatments, making them versatile tools for healthcare providers.
Key Players
The Acupuncture Lasers market is highly competitive, with several prominent players leading the way. Some of the key companies in the market include:
- MKW LaserSystem
- Lhasa OMS
- RJ-Laser
- Schwa-medico
- China Daheng Group, Inc.
- Wuxi Jiajian Medical Instruments Co., Ltd.
- Wanhe
- Hwato
- Wuhan Hnc Technology Co., Ltd.
Conclusion
The Acupuncture Lasers market is on a trajectory of continuous growth, driven by factors such as rising awareness, advancements in laser technology, the aging population, and the demand for holistic healthcare. As technology continues to evolve, acupuncture lasers will become more accessible, user-friendly, and integrated with digital health platforms, expanding their applications and improving patient outcomes. This innovative approach to an ancient healing practice is transforming the way people experience acupuncture, making it a promising avenue for both patients and healthcare practitioners.
Few Other Promising Reports In Medical Devices Industry
Surface Disinfectant Market
Sterilization Equipment And Disinfectants Market
Surgical Sinks Market
Surgical Instrument Tracking Market
Green Hospitals Market
0 notes
Text
COVID-19: Economic Impact on Reed Sensor Market 2019 Future Trends, Dynamic Growth and Forecast To 2026 | Standex International Corporation, KEMET, ZF Friedrichshafen AG
Around the world "Reed Sensor Market" this measurable reviewing report gives comprehensive and start to finish examination accessible which can help an undertaking with recognizing remunerating possibilities and help them with assembling inventive business frameworks. The market report gives information about the current market circumstance concerning the general agilely and sales, key market models and openings in the market, and inconveniences and dangers looked by the business players.
The report gives supportive pieces of information into a wide extent of business points, for instance, fragments, features, bargains structures, designing models, to interface with perusers to verify show augmentation impressively more proficiently. Additionally, the report in addition uncovers understanding into progressing new unforeseen developments and mechanical stages, paying little mind to unequivocal contraptions, and strategies for thinking that will help with moving the presentation of attempts.
Click Here To Get Global Reed Sensor Market Research Sample PDF Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-reed-sensor-market
Significant Key Market Competitors of this Global Reed Sensor Market –
Standex International Corporation, KEMET, ZF Friedrichshafen AG, Littelfuse, Inc, Airtac International Group, Aleph America Corporation, BERNSTEIN AG, COTO TECHNOLOGY, HNC Group, HSI SENSING, GEMÜ Group, ifm electronic gmbh, Madison Company, Inc, MULTICE GROUP, NTE Electronics, Inc., PIC GmbH, Reed Switch Developments Corp., Soway Tech Limited, Switch Technology Günther, Vernexx, among others.
Highlights of the Reed Sensor Market Report:
Exact market size and CAGR forecasts for the period 2019-2026.
Identification and in-depth assessment of development opportunities in key segments and regions.
Complete company profiling of top players of the Reed Sensor market.
Exhaustive research on innovation and other trends of the Reed Sensor market
Consistent industry value chain and supply chain analysis
Complete examination of key growth drivers, restraints, challenges and development prospects.
Global Reed Sensor Market Segmentation –
Sensing Type is Divided Into:
High Voltage Reed Sensor
High Temperature Reed Sensor
Metal Detection Reed Sensor
Mount Type is Divided Into:
Surface Mount Reed Sensor
Thread Mount Reed Sensor
Panel Mount Reed Sensor
Industry Vertical is Divided Into:
Automotive
Electronic
IT & Telecommunication
Healthcare
Robotics & Automation
Aerospace
Construction
Safety & Security
Others
Browse TOC with Selected illustrations and example pages of Global Reed Sensor Market @ https://www.databridgemarketresearch.com/toc/?dbmr=global-reed-sensor-market
Regional Analysis for Reed Sensor Market:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
The examination framework joined the assessment of different sections affecting the market, including the connection technique, certified scene, present and chronicled information, current market plans, mechanical turn of events, gaining upgrades and the specific ground in related endeavors, and market threats, openings, advance squares, and bothers.
Any Questions? Inquire here before purchase @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-reed-sensor-market
Motivations To Buy :-
The conveyed report is accumulated using an energetic and concentrated investigation procedure
A complete picture of the significant circumstance of "Reed Sensor" promote is depicted by this report.
The report contains an immense proportion of data about the continuous thing and inventive headways in the business areas.
It similarly gives an absolute evaluation of the ordinary lead about the future market and changing business division circumstance.
Settling on an informed business decision is a troublesome assignment; this report offers a couple of indispensable business methods to help you in choosing those choices.
To research the overall key areas advance potential and upheld position, opportunity and challenge, limitations and risks.
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Category Report:
Far-field Speech and Voice Recognition Market
Feeding Systems Market
0 notes
Video
youtube
Here is a video I created for the LOVE Group’s to advertise the launch of their online HNC in Social Services Healthcare and Children & Young People. The main aim of this video was to highlight the advantages of studying your HNC online to potential students. Showing them that they would have the flexibility to continue with their work or home life while still being able to progress their studies at a schedule that worked for them.
With the script featuring a lot of text for a 1 minute video I wanted to focus on movement and motion to keep the energy of the video up and the viewer engaged while still giving them enough time to absorb the technical content.
#video#advertising#online learning#marketing#video marketing#HNC#HNC in Social Services Healthcare and Children & Young People#Rumhann#rumhann howard hildige#motion graphics
0 notes
Text
Development of a survivorship needs assessment planning tool for head and neck cancer survivors and their caregivers: a preliminary study
Abstract
Purpose
The purpose of this study was to characterize primary end-of-treatment challenges in head and neck cancer (HNC) to drive the development of a survivorship needs assessment planning (SNAP) tool and evaluate its acceptability and feasibility.
Methods
Using qualitative methods (focus groups, interviews), we identified physical, emotional, and social post-treatment challenges from the perspectives of survivors (N = 17), caregivers (N = 14), and healthcare providers (N = 14) and pretested the SNAP tool. After Advisory Board ratings and consensus, the tool was finalized.
Results
Survivors, caregivers and clinicians consistently highlighted the importance of assessing symptoms and functional abilities (e.g., dry mouth, speech/swallowing difficulties, weight loss), health behaviors (e.g., smoking, alcohol), emotional concerns (e.g., depression, isolation, nutritional distress), and social challenges (e.g., support, finances). Caregivers were overwhelmed and intensely focused on survivors’ nutrition and trach/feeding tube care while clinicians emphasized financial and access concerns. Most participants were enthusiastic about the tool and directed a flexible care plan design due to variability in dyad needs. Over 75% reported high comfort using and navigating questions on a tablet and were in strong agreement that the care plan would help families practically and emotionally. Coordination of survivorship visits with follow-up care was critical to address travel and time barriers. While survivors and clinicians recommended waiting 1–6 months after treatment, caregivers preferred earlier survivorship visits.
Conclusions
Results pinpointed optimal end-of-treatment domains for routine assessment and support the feasibility of implementing a SNAP tool in the clinic.
Implications for Cancer Survivors
Capitalizing on technology to direct HNC survivorship care is promising.
http://ift.tt/2sruU9R
0 notes
Text
Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation
Head and neck squamous cell carcinoma is the sixth most common cancer, and its incidence is rising. The term head and neck cancer (HNC) comprises a number of malignancies that usually begin in the squamous cells that line the moist, mucosal surfaces inside the head and neck. These cancers develop inside the mouth, nose and throat. The annual incidence of head and neck cancers worldwide is more than 550,000 cases, with around 300,000 related deaths. Peak incidence occurs between the ages of 55 and 64. For Full Report Visit@ http://www.acutemarketreports.com/report/frontier-pharma-head-and-neck-cancer-immunotherapies The HNC market is characterized by a small selection of marketed product options, consisting of chemotherapies, cancer immunotherapies and receptor tyrosine kinase inhibitor products. The pipeline is moderately sized, with 340 products active across all stages of development. First-in-class products only constitute approximately a third of the pipeline, and represent 39% of products with a disclosed target. The most widely studied group of first-in-class targets are cancer immunotherapies. This has been heavily influenced by the success of Opdivo and Keytruda, which are used in the treatment of HNC (after 2016 FDA approvals) and other oncology indications. The first-in-class targets analyzed in this report have shown encouraging efficacy profiles, and some show the ability to chemosensitize cancer cells. Potential driving factors for the market include a large treatment population, the typically poor outcome, a high chance of recurrence for treated patients, a growing patient pool if disease prognosis can be improved, a lack of targeted therapy options in the market, and the strong understanding of the disease pathophysiology that has developed over the last decade, facilitating the development of novel compounds that may fulfill the unmet needs. For Full Report Visit@ http://www.acutemarketreports.com/report/frontier-pharma-head-and-neck-cancer-immunotherapies Overall, due to the highly complex and polygenic nature of HNC, which has numerous subtype classifications, it is unlikely that the inhibition of a single target will be sufficient to substantially improve patient prognosis. Instead, it is likely that the concurrent use of multiple targeted therapies alongside other available modes of therapy will improve treatment outcomes. Scope The report analyzes innovation in HNC in the context of the overall pipeline and current market landscape. It also analyzes the deals landscape surrounding first-in-class products, and pinpoints opportunities for in-licensing. A brief introduction to HNC is provided, including symptoms, pathophysiology, and an overview of pharmacotherapy and treatment algorithms. The changing molecular target landscape between the market and the pipeline is reviewed, including particular focal points of innovation in the pipeline. A comprehensive review of the pipeline for first-in-class therapies, analyzed on the basis of stage of development, molecule type and molecular target is included. First-in-class molecular targets are identified and assessed, with a particular focus on early-stage programs for which clinical utility has yet to be evaluated, as well as literature reviews on novel molecular targets. An assessment is made of the licensing and co-development deal landscape for HNC therapies. Reasons to buy Understand the current clinical and commercial landscape, including a comprehensive study of disease pathogenesis, diagnosis, prognosis and the available treatment options. Visualize the composition of the HNC market in terms of dominant molecule types and targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge enables a competitive understanding of the gaps in the market. Analyze the HNC pipeline, stratified by stage of development, molecule type and molecular target. Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been further reviewed in greater detail. Identify commercial opportunities in the HNC deals landscape by analyzing trends in licensing and co-development deals. For Full Report Visit@ http://www.acutemarketreports.com/report/frontier-pharma-head-and-neck-cancer-immunotherapies 1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 3 1.2 List of Figures 3 2 Executive Summary 4 2.1 High Unmet Need and Limited but Expanding Number of Marketed Options 4 2.2 Large but Highly Innovative Pipeline 4 2.3 Lucrative Deals Landscape, Mostly Involving Currently Established Targets 4 3 The Case for Innovation in the Head and Neck Cancer Market 5 3.1 Growing Opportunities for Biologic Products 5 3.2 Diversification of Molecular Targets 6 3.3 Innovative First-in-Class Product Developments Remain Attractive 6 3.4 Sustained Innovation 6 3.5 Report Guidance 7…………………… For Same Category Report Visit@ http://www.acutemarketreports.com/category/healthcare-market
About – Acute Market Reports: Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online. Name: Chris Paul ACUTE MARKET REPORTS Designation: Global Sales Manager Toll Free(US/CANADA): +1-855-455-8662 Email: [email protected]
0 notes
Text
Head & Neck Cancer (HNC) Market by Technological Development, Applications and Forecast 2025
Geographically, the global head & neck cancer market can be divided into five regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the global market in 2016, which is attributable to technological advancements in the medical sector in the region. However, the market in Asia Pacific is expected to expand at the maximum CAGR from 2017 to 2025, owing to the improving health care facilities in China and Japan and rising awareness among the people about diseases such as cancer. In terms of revenue, North America is estimated to remain dominant in the global head & neck cancer market during the forecast period. The rising investment by key players in R&D activities for cancer treatment with a technologically compatible and superior therapeutic approach is a major factor expected to boost the head & neck cancer market in North America during the forecast period.
Prominent players in the global head & neck cancer market are DentalEZ, Inc., Koninklijke Philips N.V., Siemens Healthcare Private Limited, AdDent Incorporated, GE Healthcare, AB SCIENCES, Bayer AG, Boston Biomedical, and Bristol-Myers Squibb Company. Prominent players in the market in developed countries are focusing on the targeted therapy segment of the head & neck cancer market.
Download Sample Copy of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22919
Head & neck cancer is characterized as a group of cancers, which initiate in squamous cells that line the mucosal surface of head and neck. It is also called squamous cell carcinoma. In the head & neck cancer, different types of malignant tumors develop in and around the larynx, throat, nose, mouth, and sinus. If the cancer is found only in the squamous layer of cells, it is known as carcinoma in situ (CIS). If the cancer grows beyond the squamous cell layer and moves deeper, it is called invasive squamous cell carcinoma. Nose, throat, and ears are the most common body parts affected by the head & neck cancer. The common symptoms include headache, common cold, change in voice, soreness in the mouth, and swelling of jaws. More than 70% of head & neck cancers are caused by alcohol and tobacco consumption. Other factors include exposure to radiations, infection by human papilloma virus (HPV) Type 16, and consumption of preserved and salted food.
Introduction of advanced chemotherapy and other treatment options and increase in per capita income of people are major factors driving the head & neck cancer market. However, high cost of targeted therapies and low awareness in developing economies about technologically advanced and novel therapies are factors expected to hamper the market for head & neck cancer during the forecast period.
The global head & neck cancer market can be segmented on the basis of type of cancer, diagnostic technique, type of treatment, and end-user.
Based on cancer type, the market has been segmented into salivary gland cancer, oropharyngeal (oral cavity) cancer, nasopharyngeal cancer, laryngeal cancer, and others. The oropharyngeal cancer segment accounted for the maximum market share in 2016. This can be attributed to the increasing consumption of tobacco and alcohol and chewing of betel nuts. Rising incidence of exposure to radiations and increasing intake of processed and raw meat as well as preserved food are the major factors anticipated to boost the oropharyngeal cancer segment of the head & neck cancer market by 2025.
Based on diagnostic technique, the global head & neck cancer market has been divided into biopsy, blood tests, diagnostic imaging equipment, endoscopy screening, and dental diagnostic equipment. The diagnostic imaging equipment segment has been further divided into PET/CT scan, MRI, and X-ray. The endoscopy screening segment has been sub-divided into pharyngoscopy, laryngoscopy, and others. In terms of revenue, the diagnostic imaging equipment segment held the maximum market share in 2016. This is due to the rising incidence of oropharyngeal cancer. X-ray and MRI segments are expected to continue to lead the market during the forecast period, owing to the rising demand for cost-effective and non-invasive diagnostic techniques.
Based on treatment type, the global head & neck cancer market has been segmented into surgery, chemotherapy, radiation therapy, targeted therapy, and others. The radiation therapy segment has been further classified into internal therapy and external therapy. Radiation therapy is the most preferred type of therapy. The segment accounted for the maximum share in the global head & neck cancer market in 2016. The radiation therapy segment and the surgery segment are expected to dominate the head & neck cancer market during the forecast period, due to the rising prevalence of head and neck cancer. On the other hand, the targeted therapy segment is expected to expand at the maximum CAGR during the forecast period, due to the increasing investment in research and development of targeted therapy by key players in the market and the rising demand for an effective and safe therapy with less side-effects.
Based on end-user, the global head & neck cancer market can be segmented into hospitals, ambulatory surgical centers, and clinics. The hospitals segment held the leading share in the global head & neck cancer market in 2016, owing to favorable reimbursement policies and the availability of well-qualified and specialized staff in hospitals. Government funding to improve the health care infrastructure in emerging economies and long-term procedures of chemotherapy and other surgeries are factors likely to propel the hospitals segment of the market for head & neck cancer by 2025.
View Report @ http://www.transparencymarketresearch.com/head-neck-cancer-market.html
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Text
Dr. Shanith Mangalat |Chairman & Founder, Ourshopee.com
Dr Shanith carries many labels with him; entrepreneur, doctor, businessman, visionary and more. The chairman and CEO of hnc Healthcare Group, founder and chairman of Ourshopee.com, founder and chairman of Ruky Perfumes, and chairman of DSR Holdings, he carries all these roles and responsibilities with utmost zeal and passion.
Website: https://www.drsholdings.ae/
0 notes
Text
Laser-Powered Holistic Healthcare: A Comprehensive Analysis of the Acupuncture Lasers Market
Introduction
Acupuncture, an ancient healing practice rooted in traditional Chinese medicine, has gained popularity worldwide for its holistic approach to health and wellness. In recent years, the integration of modern technology has given rise to the Acupuncture Lasers market, revolutionizing the way acupuncture is performed and enhancing its effectiveness. This article explores the dynamics of the Acupuncture Lasers market, including its growth drivers, market trends, key players, and the potential benefits it offers to patients.
Market Overview
The global Acupuncture Lasers market has witnessed steady growth over the past decade, driven by an increasing demand for non-invasive, painless, and efficient acupuncture therapy. Acupuncture lasers offer an alternative to traditional needle-based acupuncture, making it an attractive option for individuals who may have reservations about needles. These lasers are designed to stimulate acupuncture points on the body, promoting the flow of energy or "qi" to alleviate various health conditions.
Market Growth Drivers
1. Rising Awareness and Acceptance: Increased awareness about the effectiveness of acupuncture lasers in pain management, stress relief, and various health issues has led to growing acceptance among both patients and healthcare professionals. The shift towards natural and non-pharmacological treatment options has been a significant growth driver.
2. Advancements in Laser Technology: Continuous advancements in laser technology have improved the precision and safety of acupuncture lasers. Newer models are equipped with adjustable settings, making them suitable for a wide range of applications, from acupuncture to beauty treatments and physiotherapy.
3. Aging Population: The global population is aging, leading to a rise in chronic health conditions and pain-related issues. Acupuncture lasers are considered a viable solution for addressing these health concerns, contributing to market growth.
4. Expanding Holistic Healthcare: Many individuals are seeking holistic and alternative healthcare options. Acupuncture lasers align with this trend, offering a non-invasive and drug-free approach to healing, which has propelled their demand.
Market Trends
1. Portable and User-Friendly Devices: One of the notable trends in the Acupuncture Lasers market is the development of portable and user-friendly devices. These allow practitioners to provide treatments in diverse settings, such as homes, clinics, and wellness centers, expanding the reach of acupuncture services.
2. Integration with Digital Health: The integration of acupuncture lasers with digital health technologies, such as mobile apps and telemedicine, is becoming more common. This enables practitioners to monitor and adjust treatment plans remotely, enhancing patient outcomes.
3. Multi-Modality Platforms: Some manufacturers are incorporating multiple treatment modalities into their devices. This means that a single device can offer acupuncture, low-level laser therapy, and other complementary treatments, making them versatile tools for healthcare providers.
Key Players
The Acupuncture Lasers market is highly competitive, with several prominent players leading the way. Some of the key companies in the market include:
- MKW LaserSystem
- Lhasa OMS
- RJ-Laser
- Schwa-medico
- China Daheng Group, Inc.
- Wuxi Jiajian Medical Instruments Co., Ltd.
- Wanhe
- Hwato
- Wuhan Hnc Technology Co., Ltd.
Conclusion
The Acupuncture Lasers market is on a trajectory of continuous growth, driven by factors such as rising awareness, advancements in laser technology, the aging population, and the demand for holistic healthcare. As technology continues to evolve, acupuncture lasers will become more accessible, user-friendly, and integrated with digital health platforms, expanding their applications and improving patient outcomes. This innovative approach to an ancient healing practice is transforming the way people experience acupuncture, making it a promising avenue for both patients and healthcare practitioners.
Few Other Promising Reports In Medical Devices Industry
Surface Disinfectant Market
Sterilization Equipment And Disinfectants Market
Surgical Sinks Market
Surgical Instrument Tracking Market
Green Hospitals Market
0 notes
Text
Head & Neck Cancer (HNC) Market Research Report Forecast 2017 Analysis and Forecasts to 2025
Head & neck cancer is characterized as a group of cancers, which initiate in squamous cells that line the mucosal surface of head and neck. It is also called squamous cell carcinoma. In the head & neck cancer, different types of malignant tumors develop in and around the larynx, throat, nose, mouth, and sinus. If the cancer is found only in the squamous layer of cells, it is known as carcinoma in situ (CIS). If the cancer grows beyond the squamous cell layer and moves deeper, it is called invasive squamous cell carcinoma. Nose, throat, and ears are the most common body parts affected by the head & neck cancer. The common symptoms include headache, common cold, change in voice, soreness in the mouth, and swelling of jaws. More than 70% of head & neck cancers are caused by alcohol and tobacco consumption. Other factors include exposure to radiations, infection by human papilloma virus (HPV) Type 16, and consumption of preserved and salted food.
Get Sample Copy of this Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22919
Introduction of advanced chemotherapy and other treatment options and increase in per capita income of people are major factors driving the head & neck cancer market. However, high cost of targeted therapies and low awareness in developing economies about technologically advanced and novel therapies are factors expected to hamper the market for head & neck cancer during the forecast period.
The global head & neck cancer market can be segmented on the basis of type of cancer, diagnostic technique, type of treatment, and end-user.
Based on cancer type, the market has been segmented into salivary gland cancer, oropharyngeal (oral cavity) cancer, nasopharyngeal cancer, laryngeal cancer, and others. The oropharyngeal cancer segment accounted for the maximum market share in 2016. This can be attributed to the increasing consumption of tobacco and alcohol and chewing of betel nuts. Rising incidence of exposure to radiations and increasing intake of processed and raw meat as well as preserved food are the major factors anticipated to boost the oropharyngeal cancer segment of the head & neck cancer market by 2025.
Based on diagnostic technique, the global head & neck cancer market has been divided into biopsy, blood tests, diagnostic imaging equipment, endoscopy screening, and dental diagnostic equipment. The diagnostic imaging equipment segment has been further divided into PET/CT scan, MRI, and X-ray. The endoscopy screening segment has been sub-divided into pharyngoscopy, laryngoscopy, and others. In terms of revenue, the diagnostic imaging equipment segment held the maximum market share in 2016. This is due to the rising incidence of oropharyngeal cancer. X-ray and MRI segments are expected to continue to lead the market during the forecast period, owing to the rising demand for cost-effective and non-invasive diagnostic techniques.
Based on treatment type, the global head & neck cancer market has been segmented into surgery, chemotherapy, radiation therapy, targeted therapy, and others. The radiation therapy segment has been further classified into internal therapy and external therapy. Radiation therapy is the most preferred type of therapy. The segment accounted for the maximum share in the global head & neck cancer market in 2016. The radiation therapy segment and the surgery segment are expected to dominate the head & neck cancer market during the forecast period, due to the rising prevalence of head and neck cancer. On the other hand, the targeted therapy segment is expected to expand at the maximum CAGR during the forecast period, due to the increasing investment in research and development of targeted therapy by key players in the market and the rising demand for an effective and safe therapy with less side-effects.
Based on end-user, the global head & neck cancer market can be segmented into hospitals, ambulatory surgical centers, and clinics. The hospitals segment held the leading share in the global head & neck cancer market in 2016, owing to favorable reimbursement policies and the availability of well-qualified and specialized staff in hospitals. Government funding to improve the health care infrastructure in emerging economies and long-term procedures of chemotherapy and other surgeries are factors likely to propel the hospitals segment of the market for head & neck cancer by 2025.
Geographically, the global head & neck cancer market can be divided into five regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the global market in 2016, which is attributable to technological advancements in the medical sector in the region. However, the market in Asia Pacific is expected to expand at the maximum CAGR from 2017 to 2025, owing to the improving health care facilities in China and Japan and rising awareness among the people about diseases such as cancer. In terms of revenue, North America is estimated to remain dominant in the global head & neck cancer market during the forecast period. The rising investment by key players in R&D activities for cancer treatment with a technologically compatible and superior therapeutic approach is a major factor expected to boost the head & neck cancer market in North America during the forecast period.
View Report @ http://www.transparencymarketresearch.com/head-neck-cancer-market.html
Prominent players in the global head & neck cancer market are DentalEZ, Inc., Koninklijke Philips N.V., Siemens Healthcare Private Limited, AdDent Incorporated, GE Healthcare, AB SCIENCES, Bayer AG, Boston Biomedical, and Bristol-Myers Squibb Company. Prominent players in the market in developed countries are focusing on the targeted therapy segment of the head & neck cancer market.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
0 notes
Text
Head & Neck Cancer (HNC) Market - Market Key Trends, Size, Growth, Shares, Forecast Analysis & Outlook 2017 - 2025
Head & neck cancer is characterized as a group of cancers, which initiate in squamous cells that line the mucosal surface of head and neck. It is also called squamous cell carcinoma. In the head & neck cancer, different types of malignant tumors develop in and around the larynx, throat, nose, mouth, and sinus. If the cancer is found only in the squamous layer of cells, it is known as carcinoma in situ (CIS). If the cancer grows beyond the squamous cell layer and moves deeper, it is called invasive squamous cell carcinoma. Nose, throat, and ears are the most common body parts affected by the head & neck cancer. The common symptoms include headache, common cold, change in voice, soreness in the mouth, and swelling of jaws. More than 70% of head & neck cancers are caused by alcohol and tobacco consumption. Other factors include exposure to radiations, infection by human papilloma virus (HPV) Type 16, and consumption of preserved and salted food.
Get Sample Copy of this Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22919
Introduction of advanced chemotherapy and other treatment options and increase in per capita income of people are major factors driving the head & neck cancer market. However, high cost of targeted therapies and low awareness in developing economies about technologically advanced and novel therapies are factors expected to hamper the market for head & neck cancer during the forecast period.
The global head & neck cancer market can be segmented on the basis of type of cancer, diagnostic technique, type of treatment, and end-user.
Based on cancer type, the market has been segmented into salivary gland cancer, oropharyngeal (oral cavity) cancer, nasopharyngeal cancer, laryngeal cancer, and others. The oropharyngeal cancer segment accounted for the maximum market share in 2016. This can be attributed to the increasing consumption of tobacco and alcohol and chewing of betel nuts. Rising incidence of exposure to radiations and increasing intake of processed and raw meat as well as preserved food are the major factors anticipated to boost the oropharyngeal cancer segment of the head & neck cancer market by 2025.
Based on diagnostic technique, the global head & neck cancer market has been divided into biopsy, blood tests, diagnostic imaging equipment, endoscopy screening, and dental diagnostic equipment. The diagnostic imaging equipment segment has been further divided into PET/CT scan, MRI, and X-ray. The endoscopy screening segment has been sub-divided into pharyngoscopy, laryngoscopy, and others. In terms of revenue, the diagnostic imaging equipment segment held the maximum market share in 2016. This is due to the rising incidence of oropharyngeal cancer. X-ray and MRI segments are expected to continue to lead the market during the forecast period, owing to the rising demand for cost-effective and non-invasive diagnostic techniques.
Based on treatment type, the global head & neck cancer market has been segmented into surgery, chemotherapy, radiation therapy, targeted therapy, and others. The radiation therapy segment has been further classified into internal therapy and external therapy. Radiation therapy is the most preferred type of therapy. The segment accounted for the maximum share in the global head & neck cancer market in 2016. The radiation therapy segment and the surgery segment are expected to dominate the head & neck cancer market during the forecast period, due to the rising prevalence of head and neck cancer. On the other hand, the targeted therapy segment is expected to expand at the maximum CAGR during the forecast period, due to the increasing investment in research and development of targeted therapy by key players in the market and the rising demand for an effective and safe therapy with less side-effects.
Based on end-user, the global head & neck cancer market can be segmented into hospitals, ambulatory surgical centers, and clinics. The hospitals segment held the leading share in the global head & neck cancer market in 2016, owing to favorable reimbursement policies and the availability of well-qualified and specialized staff in hospitals. Government funding to improve the health care infrastructure in emerging economies and long-term procedures of chemotherapy and other surgeries are factors likely to propel the hospitals segment of the market for head & neck cancer by 2025.
Geographically, the global head & neck cancer market can be divided into five regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the global market in 2016, which is attributable to technological advancements in the medical sector in the region. However, the market in Asia Pacific is expected to expand at the maximum CAGR from 2017 to 2025, owing to the improving health care facilities in China and Japan and rising awareness among the people about diseases such as cancer. In terms of revenue, North America is estimated to remain dominant in the global head & neck cancer market during the forecast period. The rising investment by key players in R&D activities for cancer treatment with a technologically compatible and superior therapeutic approach is a major factor expected to boost the head & neck cancer market in North America during the forecast period.
View Report @ http://www.transparencymarketresearch.com/head-neck-cancer-market.html
Prominent players in the global head & neck cancer market are DentalEZ, Inc., Koninklijke Philips N.V., Siemens Healthcare Private Limited, AdDent Incorporated, GE Healthcare, AB SCIENCES, Bayer AG, Boston Biomedical, and Bristol-Myers Squibb Company. Prominent players in the market in developed countries are focusing on the targeted therapy segment of the head & neck cancer market.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com
0 notes
Text
Head & Neck Cancer (HNC) Market: Industry Analysis and Opportunity Assessment
Head & neck cancer is characterized as a group of cancers, which initiate in squamous cells that line the mucosal surface of head and neck. It is also called squamous cell carcinoma. In the head & neck cancer, different types of malignant tumors develop in and around the larynx, throat, nose, mouth, and sinus. If the cancer is found only in the squamous layer of cells, it is known as carcinoma in situ (CIS). If the cancer grows beyond the squamous cell layer and moves deeper, it is called invasive squamous cell carcinoma. Nose, throat, and ears are the most common body parts affected by the head & neck cancer. The common symptoms include headache, common cold, change in voice, soreness in the mouth, and swelling of jaws. More than 70% of head & neck cancers are caused by alcohol and tobacco consumption. Other factors include exposure to radiations, infection by human papilloma virus (HPV) Type 16, and consumption of preserved and salted food.
Get Sample Copy of this Report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22919
Introduction of advanced chemotherapy and other treatment options and increase in per capita income of people are major factors driving the head & neck cancer market. However, high cost of targeted therapies and low awareness in developing economies about technologically advanced and novel therapies are factors expected to hamper the market for head & neck cancer during the forecast period.
The global head & neck cancer market can be segmented on the basis of type of cancer, diagnostic technique, type of treatment, and end-user.
Based on cancer type, the market has been segmented into salivary gland cancer, oropharyngeal (oral cavity) cancer, nasopharyngeal cancer, laryngeal cancer, and others. The oropharyngeal cancer segment accounted for the maximum market share in 2016. This can be attributed to the increasing consumption of tobacco and alcohol and chewing of betel nuts. Rising incidence of exposure to radiations and increasing intake of processed and raw meat as well as preserved food are the major factors anticipated to boost the oropharyngeal cancer segment of the head & neck cancer market by 2025.
Based on diagnostic technique, the global head & neck cancer market has been divided into biopsy, blood tests, diagnostic imaging equipment, endoscopy screening, and dental diagnostic equipment. The diagnostic imaging equipment segment has been further divided into PET/CT scan, MRI, and X-ray. The endoscopy screening segment has been sub-divided into pharyngoscopy, laryngoscopy, and others. In terms of revenue, the diagnostic imaging equipment segment held the maximum market share in 2016. This is due to the rising incidence of oropharyngeal cancer. X-ray and MRI segments are expected to continue to lead the market during the forecast period, owing to the rising demand for cost-effective and non-invasive diagnostic techniques.
Based on treatment type, the global head & neck cancer market has been segmented into surgery, chemotherapy, radiation therapy, targeted therapy, and others. The radiation therapy segment has been further classified into internal therapy and external therapy. Radiation therapy is the most preferred type of therapy. The segment accounted for the maximum share in the global head & neck cancer market in 2016. The radiation therapy segment and the surgery segment are expected to dominate the head & neck cancer market during the forecast period, due to the rising prevalence of head and neck cancer. On the other hand, the targeted therapy segment is expected to expand at the maximum CAGR during the forecast period, due to the increasing investment in research and development of targeted therapy by key players in the market and the rising demand for an effective and safe therapy with less side-effects.
Based on end-user, the global head & neck cancer market can be segmented into hospitals, ambulatory surgical centers, and clinics. The hospitals segment held the leading share in the global head & neck cancer market in 2016, owing to favorable reimbursement policies and the availability of well-qualified and specialized staff in hospitals. Government funding to improve the health care infrastructure in emerging economies and long-term procedures of chemotherapy and other surgeries are factors likely to propel the hospitals segment of the market for head & neck cancer by 2025.
Geographically, the global head & neck cancer market can be divided into five regions viz. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the global market in 2016, which is attributable to technological advancements in the medical sector in the region. However, the market in Asia Pacific is expected to expand at the maximum CAGR from 2017 to 2025, owing to the improving health care facilities in China and Japan and rising awareness among the people about diseases such as cancer. In terms of revenue, North America is estimated to remain dominant in the global head & neck cancer market during the forecast period. The rising investment by key players in R&D activities for cancer treatment with a technologically compatible and superior therapeutic approach is a major factor expected to boost the head & neck cancer market in North America during the forecast period.
Prominent players in the global head & neck cancer market are DentalEZ, Inc., Koninklijke Philips N.V., Siemens Healthcare Private Limited, AdDent Incorporated, GE Healthcare, AB SCIENCES, Bayer AG, Boston Biomedical, and Bristol-Myers Squibb Company. Prominent players in the market in developed countries are focusing on the targeted therapy segment of the head & neck cancer market.
View Report @ http://www.transparencymarketresearch.com/head-neck-cancer-market.html
About Transparency Market Research Pvt. Ltd.
Transparency Market Research (TMR) is a next-generation provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact info
90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected] Website: www.transparencymarketresearch.com
0 notes